This represents a $1.08 annualized dividend and a dividend yield of 0.52%. Investors should closely monitor any recent news or events that may have impacted Danaher’s share price, such libertex overview as industry developments or major acquisitions. Its competitive advantages, including a broad product portfolio and emphasis on innovation, position it well within its industries.
Danaher’s strong financials indicate its ability to generate revenue and profits, which has positively influenced investor sentiment and contributed to its favorable valuation. The conglomerate has completed the spinoff of its environmental and applied solutions segment into a new company, Veralto. Traders should take this into account as the share price often fluctuates around this time period.
Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. After each calculation the program stages of team development assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. For example, a price above its moving average is generally considered an upward trend or a buy. Danaher saw a decrease in short interest in the month of September.
The company was founded in 1969 and is headquartered in Washington, the District of Columbia. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.17% per year. These returns cover a period from January 1, 1988 through September 4, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.
- Over the past month, the Zacks Consensus EPS estimate has shifted 0.16% downward.
- A thumbnail of a daily chart is provided, with a link to open and customize a full-sized chart.
- Royal Bank of Canada lifted their price target on Danaher from $260.00 to $292.00 in a research note on Wednesday, July 26th.
- Recent stocks from this report have soared up to +178.7% in 3 months – this month’s picks could be even better.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $8.82 per share and a revenue of $28.49 billion, indicating changes of -19.45% and -9.47%, respectively, from the former year. In the latest market close, Danaher (DHR Quick QuoteDHR – Free Report) reached $209.43, with a -0.03% movement compared to the previous day. The stock’s change was more than the S&P 500’s daily loss of 0.5%. At the same time, the Dow added 0.12%, and the tech-heavy Nasdaq lost 1.23%.
Stifel Nicolaus decreased their price target on Danaher from $250.00 to $240.00 and set a «hold» rating for the company in a research report on Wednesday, July 26th. Raymond James lifted their price objective on Danaher from $270.00 to $290.00 and gave the company an «outperform» rating in a research note on Wednesday, July 26th. Wells Fargo & Company dropped their price objective on Danaher from $285.00 to $247.00 and set an «overweight» rating for the company in a research note on Tuesday, October 3rd. Royal Bank of Canada lifted their price target on Danaher from $260.00 to $292.00 in a research note on Wednesday, July 26th. Finally, KeyCorp lowered their target price on Danaher from $325.00 to $300.00 and set an «overweight» rating for the company in a research note on Wednesday, September 27th. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock.
Danaher Corp. stock falls Friday, still outperforms market
27 employees have rated Danaher Chief Executive Officer Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among the company’s employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies. The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
- Provides a general description of the business conducted by this company.
- In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.
- Danaher caters to various markets, including healthcare, life sciences, diagnostics, environmental monitoring, and industrial automation.
- The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.
- The company’s diverse product portfolio includes cutting-edge medical diagnostic devices, scientific instruments used in research and healthcare settings, water quality monitoring systems, and automation equipment for industrial applications.
Get this delivered to your inbox, and more info about our products and services. Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next days. The Diversified Operations industry is part of the Conglomerates sector. With its current Zacks Industry Rank of 156, this industry ranks in the bottom 39% of all industries, numbering over 250.
There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. There’s life after COVID-19 for Danaher, and the stock has a long pathway of growth ahead of it. These exchange-traded funds track companies in this biotech space.
Danaher (DHR) Stock Moves -0.03%: What You Should Know
As of September 30th, there was short interest totaling 5,720,000 shares, a decrease of 9.4% from the September 15th total of 6,310,000 shares. Based on an average daily volume of 2,740,000 shares, the short-interest ratio is presently 2.1 days. Danaher has ample growth opportunities, including expansion into emerging markets, strategic acquisitions, and research and development 5 day trading strategies investments. The company’s strong focus on continuous improvement and customer-centric solutions will drive its pursuit of growth opportunities. Danaher has displayed excellent financial performance in recent years, with consistent revenue growth and profitability. The company’s financial stability and strategic acquisitions have contributed to its robust performance.
To exploit this, we’ve formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
Premium Investing Services
Danaher is involved in designing, manufacturing, and marketing a broad array of products and services. Its offerings span medical diagnostics equipment, life sciences and diagnostics tools, environmental solutions, water quality analysis systems, industrial automation tools, and other specialized instruments. Danaher’s mission is to leverage its technological expertise and commitment to continuous improvement to develop innovative solutions that enhance human well-being and drive sustainable growth. Danaher’s mission is to innovate and provide high-quality solutions that positively impact people’s lives worldwide.
These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts’ confidence in the company’s business performance and profit potential. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation. MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on…
One should further note that DHR currently holds a PEG ratio of 2.26. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company’s expected earnings growth trajectory. The Diversified Operations was holding an average PEG ratio of 1.87 at yesterday’s closing price. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.16% downward. It is also important to note the recent changes to analyst estimates for Danaher.
Danaher (DHR) Gains But Lags Market: What You Should Know
The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The life sciences and diagnostics company’s guidance is getting complicated. Click the link below and we’ll send you MarketBeat’s list of the 10 best stocks to own in 2023 and why they should be in your portfolio. Recent stocks from this report have soared up to +178.7% in 3 months – this month’s picks could be even better. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.